|
Note 9 - Derivatives (Details) (USD $)
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2011
|
Oct. 01, 2012
|
| Note 9 - Derivatives (Details) [Line Items] |
|
|
|
|
| Derivative Liability |
$ 0 |
$ 0 |
|
|
| Series C Preferred Stock [Member] | DC Bio [Member] |
|
|
|
|
| Note 9 - Derivatives (Details) [Line Items] |
|
|
|
|
| Preferred Stock, Capital Shares Reserved for Future Issuance (in Shares) |
|
|
652,608 |
|
| Series B Preferred Stock [Member] | DC Bio [Member] |
|
|
|
|
| Note 9 - Derivatives (Details) [Line Items] |
|
|
|
|
| Preferred Stock, Capital Shares Reserved for Future Issuance (in Shares) |
|
|
419,768 |
|
| Common Stock [Member] | DC Bio [Member] |
|
|
|
|
| Note 9 - Derivatives (Details) [Line Items] |
|
|
|
|
| Preferred Stock, Capital Shares Reserved for Future Issuance (in Shares) |
|
|
23,703 |
|
| DC Bio [Member] |
|
|
|
|
| Note 9 - Derivatives (Details) [Line Items] |
|
|
|
|
| Derivative Liability |
|
|
1,036,403 |
|
| Business Transaction Fair Value of Shares Issuable on Option Exercise |
|
|
1,487,668 |
|
| Business Transaction Fair Value of Exchangeable Shares |
|
|
451,265 |
|
| Proceeds from Disposal of Non-controlling Interest |
|
|
|
$ 180,000 |